arginine vasopressin has been researched along with niravoline in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (85.71) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angeli, P; Arroyo, V; Bosch-Marcé, M; Clària, J; Graziotto, A; Jiménez, W; Leivas, A; Rivera, F; Rodés, J | 1 |
| Ben-Ishay, D; Yagil, C; Yagil, Y | 1 |
| Kim, JK; Rossi, NF; Schrier, RW; Summers, SN | 1 |
| Kim, JK; Schrier, RW; Summer, SN | 1 |
| Ikeda, Y; Kawamoto, T; Teramoto, A; Toda, S | 1 |
| Ikeda, Y; Ishibashi, Y; Nakagawa, Y; Teramoto, A; Yoshii, T | 1 |
| Hamada, H; Takahashi, H; Teramoto, A | 1 |
7 other study(ies) available for arginine vasopressin and niravoline
| Article | Year |
|---|---|
Aquaretic effect of the kappa-opioid agonist RU 51599 in cirrhotic rats with ascites and water retention.
Topics: Analysis of Variance; Animals; Arginine Vasopressin; Ascites; Benzeneacetamides; Blood Pressure; Body Water; Diuresis; Heart Rate; Kidney; Liver Cirrhosis, Experimental; Male; Natriuresis; Pyrrolidines; Rats; Rats, Wistar; Receptors, Opioid, kappa; Vasopressins | 1995 |
Disparate expression of the AVP gene in Sabra hypertension-prone and hypertension-resistant rats.
Topics: Animals; Arginine Vasopressin; Benzeneacetamides; Gene Expression; Genetic Predisposition to Disease; Hypertension; Hypothalamus; Male; Osmolar Concentration; Plasma; Pyrrolidines; Rats; Rats, Inbred Strains; RNA, Messenger; Sodium Chloride; Water; Water Deprivation | 1996 |
Kappa opiate agonist RU 51599 inhibits vasopressin gene expression and osmotically-induced vasopressin secretion in vitro.
Topics: Animals; Arginine Vasopressin; Benzeneacetamides; Dose-Response Relationship, Drug; Hypothalamo-Hypophyseal System; Male; Osmolar Concentration; Pyrrolidines; Rats; Receptors, Opioid, kappa; RNA, Messenger | 1997 |
Effect of kappa opioid agonist RU 51599 on osmotic and non-osmotic stimulated arginine vasopressin release and gene regulation in small cell lung carcinoma cells.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Benzeneacetamides; Carcinoma, Small Cell; Endothelin-3; Gene Expression Regulation, Neoplastic; Lung Neoplasms; Osmolar Concentration; Promoter Regions, Genetic; Pyrrolidines; Rats; Receptors, Opioid, kappa; Stimulation, Chemical; Tumor Cells, Cultured | 1997 |
Arginine vasopressin release inhibitor RU51599 attenuates brain oedema following transient forebrain ischaemia in rats.
Topics: Animals; Arginine Vasopressin; Benzeneacetamides; Brain Chemistry; Brain Edema; Brain Ischemia; Cerebral Cortex; Diuretics; Male; Microdialysis; Prosencephalon; Pyrrolidines; Rats; Rats, Wistar; Receptors, Opioid, kappa | 1997 |
Attenuation of cryogenic induced brain oedema by arginine vasopressin release inhibitor RU51599.
Topics: Animals; Arginine Vasopressin; Benzeneacetamides; Blood-Brain Barrier; Brain Chemistry; Brain Edema; Brain Injuries; Cold Temperature; Diuretics; Evans Blue; Male; Naloxone; Potassium; Pyrrolidines; Rats; Rats, Wistar; Receptors, Opioid, kappa; Sodium; Spectrophotometry, Atomic | 1997 |
Usefulness of niravoline, an arginine vasopressin inhibitor, on tumour-origin brain oedema.
Topics: Animals; Arginine Vasopressin; Benzeneacetamides; Brain; Brain Edema; Brain Neoplasms; Female; Glioma; Injections, Intravenous; Neoplasm Transplantation; Pyrrolidines; Rats; Rats, Wistar; Tumor Cells, Cultured; Water-Electrolyte Balance | 2000 |